4//SEC Filing
WIENS HAROLD J 4
Accession 0000914190-19-000460
CIK 0000842023other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:50 PM ET
Size
23.1 KB
Accession
0000914190-19-000460
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
WIENS HAROLD J
Director
Transactions
- Sale
Common Stock
2019-12-04$216.47/sh−485$104,990→ 6,736 total - Sale
Common Stock
2019-12-04$219.31/sh−80$17,545→ 5,221 total - Exercise/Conversion
Common Stock
2019-12-04$87.83/sh+2,000$175,660→ 7,221 total - Sale
Common Stock
2019-12-04$217.29/sh−514$111,685→ 6,222 total - Sale
Common Stock
2019-12-04$218.75/sh−921$201,473→ 5,301 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-04−2,000→ 0 totalExercise: $87.83From: 2014-05-15Exp: 2024-05-15→ Common Stock (2,000 underlying)
Holdings
- 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 3,125
Stock Option (right to buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 1,898
Stock Option (right to buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying) - 3,985
Stock Option (right to buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-26→ Common Stock (3,985 underlying) - 2,011
Stock Option (right to buy)
Exercise: $201.64Exp: 2029-10-24→ Common Stock (2,011 underlying) - 4,000
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying)
Footnotes (6)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne's 2020 annual meeting of shareholders.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2019.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.00 to $216.94, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.21 to $217.54, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.28 to $218.96, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.31 to $219.32, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001197788
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:50 PM ET
- Size
- 23.1 KB